FDA Approval Semaglutide : Approved for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy)
This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
When to Seek Medical Attention for Tirzepatide Side Effects Body aches lasting more than three weeks, severe joint swelling, or muscle weakness warrant evaluation by a healthcare provider, as these may indicate pancreatitis, autoimmune response, or unrelated conditions
Various nutrient-sensing receptors distributed in the vagal terminal in the gut are crucial for signal transduction from the gut to the brain